U.S. Perficient, Target, Vertex Pharmaceuticals
May 7 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Perficient, Target and Vertex Pharmaceuticals, on Tuesday.
HIGHLIGHTS
* Cerence Inc CRNC.O: Needham cuts to hold from buy |
* Gap Inc GPS.N: Citigroup raises to buy from neutral |
* Perficient Inc PRFT.O: Alliance Global Partners cuts to neutral from buy |
* Target Corp TGT.N: Citigroup raises to buy from neutral |
* Vertex Pharmaceuticals Inc VRTX.O: Piper Sandler raises target price to $456 from $450 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Acadia Healthcare Company Inc ACHC.O: TD Cowen cuts target price to $91 from $101 |
* Adc Therapeutics SA ADCT.N: H.C. Wainwright cuts target price to $8 from $9 |
* Affiliated Managers Group Inc AMG.N: TD Cowen cuts target price to $198 from $218 |
* AG Mortgage Investment Trust Inc MITT.N: KBW raises target price to $7.50 from $7 |
* AIG AIG.N: BMO cuts target price to $88 from $91 |
* AIG AIG.N: Jefferies raises target price to $92 from $88 |
* Air Lease Corp AL.N: JP Morgan cuts target price to $54 from $55 |
* Air Lease Corp AL.N: TD Cowen cuts target price to $56 from $59 |
* Albemarle Corp ALB.N: Deutsche Bank raises target price to $140 from $125 |
* Alibaba Group BABA.N: Truist Securities cuts target price to $113 from $114 |
* Allegheny Technologies Inc ATI.N: JP Morgan raises target price to $65 from $53 |
* Allstate Corp ALL.N: BMO raises target price to $190 from $182 |
* Alnylam Pharmaceuticals Inc ALNY.O: H.C. Wainwright raises target to $400 from $395 |
* American Financial Group Inc AFG.N: BMO cuts target price to $133 from $136 |
* APA Corporation APA.O: Susquehanna raises target price to $57 from $54 |
* Archrock Inc AROC.N: RBC raises target price to $22 from $21 |
* Arcosa Inc ACA.N: Stephens raises target price to $96 from $89 |
* Ares Management Corp ARES.N: RBC raises target price to $150 from $145 |
* Ares Management Corp ARES.N: TD Cowen initiates coverage with buy rating; PT $154 |
* Arrow Electronics Inc ARW.N: Raymond James raises target price to $135 from $130 |
* Artivion Inc AORT.N: Needham raises target price to $30 from $25 |
* Artivion Inc AORT.N: Stifel raises target price to $25 from $22 |
* Ashland Inc ASH.N: BMO raises target price to $105 from $97 |
* Autozone Inc AZO.N: Citigroup cuts target price to $3420 from $3505 |
* Axon Enterprise Inc AXON.O: Craig-Hallum raises target price to $370 from $325 |
* Axon Enterprise Inc AXON.O: Raymond James raises target price to $400 from $330 |
* Axsome Therapeutics Inc AXSM.O: Citigroup cuts target price to $125 from $127 |
* Beacon Roofing Supply Inc BECN.O: Stephens raises target price to $107 from $95 |
* Best buy Co Inc BBY.N: Citigroup cuts target price to $67 from $76 |
* Biocryst Pharmaceuticals Inc BCRX.O: Piper Sandler raises target price to $20 from $19 |
* Bowlero Corp BOWL.N: Craig-Hallum raises target price to $18 from $17 |
* Bowlero Corp BOWL.N: Jefferies cuts target price to $29 from $30 |
* Bowlero Corp BOWL.N: Oppenheimer cuts target price to $15 from $18 |
* Bowlero Corp BOWL.N: Stifel cuts target price to $17 from $19 |
* BP BP.N: TD Cowen raises target price to $44 from $43 |
* Brightview Holdings Inc BV.N: JP Morgan raises target price to $11 from $8 |
* Builders Firstsource Inc BLDR.N: Wedbush cuts target price to $215 from $225 |
* BWX Technologies Inc BWXT.N: Deutsche Bank cuts target price to $110 from $111 |
* Cabot Corp CBT.N: Mizuho raises target price to $109 from $104 |
* Cabot Corp CBT.N: UBS raises target price to $103 from $100 |
* Cameco Corp CCJ.N: BofA Global Research adds stock to its US 1 list |
* Cardinal Health Inc CAH.N: Deutsche Bank cuts target price to $110 from $116 |
* Cardinal Health Inc CAH.N: Jefferies cuts target price to $105 from $110 |
* Cerence Inc CRNC.O: Needham cuts to hold from buy |
* Chewy Inc CHWY.N: Citigroup cuts target price to $16 from $18 |
* Children'S Place Inc PLCE.O: Telsey Advisory Group cuts target price to $9 from $13 |
* Cipher Mining Inc CIFR.O: H.C. Wainwright raises target price to $5.50 from $4.50 |
* City Holding Co CHCO.O: D.A. Davidson cuts target price by $1 to $107 |
* Civitas Resources Inc CIVI.N: Gerdes Energy Research raises target price by $2 to $115 |
* Cognex Corp CGNX.O: Truist Securities raises target price to $50 from $47 |
* Consolidated Edison Inc ED.N: Barclays raises target price to $97 from $89 |
* Constellation Energy Corp CEG.O: RBC raises target price to $211 from $119 |
* Corning Inc GLW.N: Mizuho initiates coverage with neutral rating; target price $36 |
* Corvus Pharmaceuticals CRVS.O: Oppenheimer raises target price to $8 from $7 |
* Coterra Energy Inc CTRA.N: Susquehanna raises target price to $33 from $32 |
* Coty Inc COTY.N: D.A. Davidson cuts target price to $16.50 from $17.50 |
* Crinetics Pharmaceuticals Inc CRNX.O: Piper Sandler raises PT to $97 from $56 |
* Crocs Inc CROX.O: Wedbush raises target price to $156 from $154 |
* Crown Castle Inc CCI.N: RBC cuts target price to $100 from $109 |
* CTO Realty Growth Inc CTO.N: Jonestrading cuts target price to $19 from $21 |
* CVS Health Corp CVS.N: TD Cowen cuts target price to $59 from $99 |
* CVS Health Corp CVS.N: TD Cowen cuts to hold from buy |
* Day One Biopharmaceuticals Inc DAWN.O: H.C. Wainwright cuts target to $40 from $50 |
* Design Therapeutics Inc DSGN.O: Piper Sandler raises target price to $12 from $6 |
* Design Therapeutics Inc DSGN.O: Piper Sandler raises to overweight from neutral |
* Dollar General Corp DG.N: BMO cuts target price to $150 from $160 |
* Dollar Tree Inc DLTR.O: BMO cuts target price to $150 from $160 |
* DR Horton Inc DHI.N: KBW raises target price to $178 from $172 |
* Driven Brands Holdings Inc. DRVN.O: Barclays cuts target price to $22 from $25 |
* eBay Inc EBAY.O: Deutsche Bank cuts target price to $56 from $58 |
* Edwards Lifesciences Corp EW.N: Barclays raises target price to $101 from $100 |
* Ehealth Inc EHTH.O: Craig-Hallum cuts target price to $6 from $7 |
* Eledon Pharmaceuticals Inc ELDN.O: H.C. Wainwright raises target price to $16 from $13 |
* Enact Holdings Inc ACT.O: BTIG raises target price to $33 from $30 |
* Enanta Pharmaceuticals Inc ENTA.O: H.C. Wainwright cuts target price to $27 from $28 |
* Enanta Pharmaceuticals Inc ENTA.O: Leerink Partners cuts target price to $12 from $13 |
* Enanta Pharmaceuticals Inc ENTA.O: Oppenheimer cuts target price to $16 from $17 |
* Equitable Holdings Inc EQH.N: KBW raises target price to $43 from $41 |
* Everquote Inc EVER.O: Craig-Hallum raises target price to $30 from $26 |
* Everquote Inc EVER.O: JP Morgan raises target price to $29 from $25 |
* Everquote Inc EVER.O: Needham raises target price to $30 from $25 |
* Exelon Corp EXC.O: RBC raises target price to $41 from $37 |
* Exxon Mobil Corp XOM.N: UBS raises target price to $152 from $150 |
* Eyepoint Pharmaceuticals Inc EYPT.O: Mizuho cuts target price to $30 from $39 |
* Fabrinet FN.N: Rosenblatt Securities raises target price to $260 from $230 |
* First Citizens Bancshares FCNCA.O: D.A. Davidson raises target price by $200 to $1,850 |
* FIS FIS.N: Evercore ISI raises target price to $80 from $75 |
* FIS FIS.N: Jefferies raises target price to $75 from $70 |
* FIS FIS.N: RBC raises target price to $82 from $75 |
* FMC Corp FMC.N: Mizuho raises target price to $57 from $55 |
* FMC Corp FMC.N: UBS raises target price to $86 from $84 |
* Freshpet Inc FRPT.O: D.A. Davidson raises target price to $153 from $138 |
* Freshpet Inc FRPT.O: Jefferies raises target price to $118 from $105 |
* Freshpet Inc FRPT.O: JP Morgan raises target price to $113 from $102 |
* Freshpet Inc FRPT.O: Oppenheimer raises target price to $135 from $120 |
* Freshpet Inc FRPT.O: Piper Sandler raises target price to $150 from $130 |
* Freshpet Inc FRPT.O: TD Cowen raises target price to $143 from $128 |
* Freshpet Inc FRPT.O: Wells Fargo raises target price to $140 from $124 |
* Frontier Communications Parent Inc FYBR.O: Citigroup raises target to $32 from $30 |
* Frontier Communications Parent Inc FYBR.O: Moffettnathanson raises PT to $30 from $28 |
* Fulton Financial Corp FULT.O: Stephens raises target price to $17.5 from $15.5 |
* Galiano Gold Inc GAU.N: H.C. Wainwright raises target price to $4.40 from $4.30 |
* Gap Inc GPS.N: Citigroup raises target price to $28 from $21 |
* Gap Inc GPS.N: Citigroup raises to buy from neutral |
* Gladstone Commercial Corp GOOD.O: Colliers Securities raises target price by $1 to $15 |
* Glycomimetics Inc GLYC.O: Jefferies cuts target price to $1 from $3 |
* Gossamer Bio Inc GOSS.O: Leerink Partners raises target price to $6 from $3 |
* Heidrick & Struggles International HSII.O: Truist Securities raises PT to $33 from $30 |
* Hims & Hers Health Inc HIMS.N: Deutsche Bank raises target price to $16 from $14 |
* Hims & Hers Health Inc HIMS.N: Guggenheim raises target price to $20 from $17 |
* Hims & Hers Health Inc HIMS.N: Leerink Partners cuts target price to $15 from $18 |
* Hims & Hers Health Inc HIMS.N: Piper Sandler raises target price to $13 from $11 |
* Home Depot Inc HD.N: Citigroup cuts target price to $395 from $415 |
* Homestreet Inc HMST.O: KBW cuts target price to $13.50 from $15.50 |
* Howmet Aerospace Inc HWM.N: JP Morgan raises target price to $83 from $60 |
* Huntsman Corp HUN.N: RBC raises target price to $26 from $24 |
* Ingersoll Rand Inc IR.N: Citigroup cuts target price to $110 from $112 |
* Ingersoll Rand Inc IR.N: Stifel cuts target price to $100 from $102 |
* Integra Lifesciences Holdings Corp IART.O: Jefferies cuts target price to $48 from $50 |
* Integra Lifesciences Holdings Corp IART.O: Morgan Stanley cuts target to $24 from $37 |
* Integra Lifesciences Holdings Corp IART.O: Oppenheimer cuts to perform from outperform |
* Integra Lifesciences Holdings Corp IART.O: Truist Securities cuts PT to $25 from $37 |
* International Flavors & Fragrances Inc IFF.N: Mizuho raises PT to $98 from $91 |
* International Flavors & Fragrances Inc IFF.N: Stifel raises PT to $95.00 from $87.00 |
* International Flavors & Fragrances Inc IFF.N: UBS raises target price to $95 from $90 |
* Intest Corp INTT.A: Northland Capital cuts target price to $15 from $17 |
* Kilroy Realty Corp KRC.N: Evercore ISI cuts target price to $39 from $40 |
* Lemonade Inc LMND.N: BMO raises target price to $11 from $10 |
* Lemonade Inc LMND.N: Jefferies raises target price to $16 from $14 |
* Liberty Latin America LILA.O: Barclays cuts target price to $8 from $9 |
* Lincoln Educational Services LINC.O: Barrington Research raises target to $14 from $13 |
* Lincoln Educational Services LINC.O: Rosenblatt Securities raises PT to $15 from $13.5 |
* Lowe's Companies Inc LOW.N: Citigroup cuts target price to $240 from $243 |
* Lumentum Holdings Inc LITE.O: Barclays cuts target price to $38 from $40 |
* Lumentum Holdings Inc LITE.O: Jefferies cuts target price to $53 from $57 |
* Lumentum Holdings Inc LITE.O: Raymond James cuts target price to $55 from $58 |
* Lumentum Holdings Inc LITE.O: UBS cuts target price to $51 from $52 |
* Lyra Therapeutics Inc LYRA.O: Jefferies cuts target price to $0.5 from $10 |
* Lyra Therapeutics Inc LYRA.O: Jefferies cuts to hold from buy |
* Marinus Pharmaceuticals Inc MRNS.O: H.C. Wainwright cuts target price to $11 |
* Marriott Vacations Worldwide Corp VAC.N: Stifel raises PT to $117.00 from $115.00 |
* Mastec Inc MTZ.N: D.A. Davidson raises target price to $120 from $100 |
* Mediaalpha Inc MAX.N: BMO raises target price to $31 from $28 |
* Metagenomi Inc MGX.O: H.C. Wainwright initiates coverage with buy rating |
* Metlife Inc MET.N: KBW cuts target price to $86 from $87 |
* Microchip Technology Inc MCHP.O: Citigroup raises target price to $104 from $100 |
* Microchip Technology Inc MCHP.O: Mizuho raises target price to $85 from $82 |
* Microchip Technology Inc MCHP.O: Needham raises target price to $100 from $90 |
* Microchip Technology Inc MCHP.O: Piper Sandler raises target price to $90 from $80 |
* Microchip Technology Inc MCHP.O: Raymond James raises target price to $105 from $100 |
* Microchip Technology Inc MCHP.O: Susquehanna raises target price to $105 from $100 |
* Microchip Technology Inc MCHP.O: TD Cowen raises target price to $90 from $80 |
* Microchip Technology Inc MCHP.O: Truist Securities raises target price to $96 from $93 |
* Microchip Technology Inc MCHP.O: UBS raises target price to $103 from $95 |
* Moderna Inc MRNA.O: UBS raises target price to $151 from $143 |
* Moneylion Inc ML.N: Craig-Hallum raises target price to $105 from $100 |
* Moody's Corp MCO.N: Stifel raises target price to $374 from $350 |
* MP Materials Corp MP.N: Deutsche Bank cuts target price to $14.5 from $15 |
* Napco Security Technologies Inc NSSC.O: D.A. Davidson raises target to $53 from $52 |
* Napco Security Technologies Inc NSSC.O: Needham raises target price to $52 from $46 |
* Nexpoint Real Estate Finance Inc NREF.N: KBW cuts target price to $13.50 from $14 |
* Nextera Energy Inc NEE.N: BMO raises target price to $78 from $72 |
* Nike Inc NKE.N: BofA Global Research adds stock to its US 1 list |
* Northwest Natural Holding Co NWN.N: Stifel raises target price to $40 from $39 |
* Nvidia Corp NVDA.O: Goldman Sachs raises target price to $1100 from $1000 |
* Offerpad Solutions Inc OPAD.N: JP Morgan cuts target price to $8 from $9 |
* Omnicom Group Inc OMC.N: Barclays raises target price to $110 from $100 |
* Omnicom Group Inc OMC.N: Barclays raises to overweight from equal-weight |
* Oric Pharmaceuticals Inc ORIC.O: Citigroup cuts target price to $14 from $15 |
* Orthopediatrics Corp KIDS.O: Needham raises target price to $42 from $37 |
* Ovid Therapeutics Inc OVID.O: Citigroup cuts target price to $3.5 from $4 |
* Pacs Group Inc PACS.N: Stephens initiates coverage with overweight rating and $31 PT |
* Pactiv Evergreen Inc PTVE.O: Citigroup cuts target price to $16 from $17 |
* Palantir Technologies Inc PLTR.N: Citigroup raises target price to $25 from $23 |
* Palantir Technologies Inc PLTR.N: D.A. Davidson raises target price to $24 from $19 |
* Palantir Technologies Inc PLTR.N: Deutsche Bank raises target price to $20 from $18 |
* Palantir Technologies Inc PLTR.N: HSBC raises target price to $23 from $22 |
* Palantir Technologies Inc PLTR.N: RBC raises target price to $9 from $5 |
* Paymentus Holdings Inc PAY.N: Citigroup raises target price to $22 from $20 |
* Perficient Inc PRFT.O: Alliance Global Partners cuts to neutral from buy |
* Perficient Inc PRFT.O: Barrington Research cuts to market perform from outperform |
* Petco Health and Wellness Co WOOF.O: Citigroup cuts target price to $1.75 from $2.85 |
* Pinnacle West Capital Corp PNW.N: Evercore ISI raises target price to $77 from $69 |
* Pliant Therapeutics Inc PLRX.O: Citigroup cuts target price to $44 from $45 |
* Pliant Therapeutics Inc PLRX.O: H.C. Wainwright cuts target price to $36 from $48 |
* Pliant Therapeutics Inc PLRX.O: Oppenheimer raises target price to $48 from $47 |
* Pliant Therapeutics Inc PLRX.O: RBC cuts target price to $45 from $54 |
* Post Holdings Inc POST.N: Barclays raises target price to $120 from $115 |
* Prime Medicine Inc PRME.O: Jefferies assumes coverage with buy rating; PT $15 vs $23 |
* Public Service Enterprise Group Inc PEG.N: RBC raises target price to $80 from $72 |
* Pyxis Oncology Inc PYXS.O: Jefferies assumes coverage with buy rating; PT $10 |
* Rani Therapeutics Holdings Inc RANI.O: H.C. Wainwright raises target to $13 from $12 |
* Regeneron Pharmaceuticals Inc REGN.O: UBS raises target price to $1,124 from $1,099 |
* Reinsurance Group of America Inc RGA.N: KBW raises target price to $235 from $220 |
* Rocket Companies Inc RKT.N: Piper Sandler raises target price to $13 from $12 |
* Rocket Lab USA Inc RKLB.O: Citigroup cuts target price to $5.45 from $6 |
* Root Inc ROOT.O: KBW raises target price to $80 from $70 |
* Rxsight Inc RXST.O: BTIG raises target price to $72 from $61 |
* Rxsight Inc RXST.O: JP Morgan raises target price to $75 from $62 |
* Rxsight Inc RXST.O: Needham raises target price to $75 from $64 |
* Rxsight Inc RXST.O: Oppenheimer raises target price to $72 from $61 |
* Sarepta Therapeutics Inc SRPT.O: Guggenheim raises target price to $148 from $145 |
* Schneider National Inc SNDR.N: Stephens cuts target price to $24 from $30 |
* Selective Insurance Group Inc SIGI.O: BMO cuts target price to $100 from $105 |
* ServiceNow Inc NOW.N: Baird raises target price to $885 from $870 |
* Shake Shack Inc SHAK.N: Stifel raises target price to $110 from $95 |
* Shoals Technologies Group Inc SHLS.O: Guggenheim cuts target price to $12 from $14 |
* Silverbow Resources Inc SBOW.N: Truist Securities raises target price to $47 from $45 |
* Slb SLB.N: BofA Global Research removes stock from its US 1 list |
* Southern Co SO.N: RBC raises target price to $84 from $80 |
* Spirit Airlines SAVE.N: Deutsche Bank cuts target price to $3 from $4 |
* Spirit Airlines SAVE.N: Evercore ISI cuts target price to $3 from $3.50 |
* Spirit Airlines SAVE.N: TD Cowen cuts target price to $3 from $4 |
* Stoke Therapeutics Inc STOK.O: Canaccord Genuity cuts target price to $20 from $21 |
* Summit Therapeutics Inc SMMT.O: Citigroup initiates coverage With Buy rating; PT $7 |
* Symbotic Inc SYM.O: Craig-Hallum raises target price to $60 from $55 |
* Symbotic Inc SYM.O: Deutsche Bank raises target price to $58 from $57 |
* Synovus Financial Corp SNV.N: D.A. Davidson raises target price to $47 from $43 |
* Talos Energy Inc TALO.N: Stephens cuts target price to $24 from $26 |
* Target Corp TGT.N: Citigroup raises to buy from neutral |
* Teradata Corp TDC.N: Barclays cuts target price to $35 from $39 |
* Teradata Corp TDC.N: BofA Global Research cuts price objective to $39 from $48 |
* Teradata Corp TDC.N: BofA Global Research cuts to underperform from neutral |
* Teradata Corp TDC.N: Evercore ISI cuts target price to $46 from $58 |
* Teradata Corp TDC.N: Guggenheim cuts target price to $60 from $66 |
* Teradata Corp TDC.N: RBC cuts target price to $44 from $48 |
* Teradata Corp TDC.N: TD Cowen cuts target price to $40 from $46 |
* Territorial Bancorp Inc TBNK.O: Piper Sandler raises target price to $8.50 from $8 |
* Territorial Bancorp Inc TBNK.O: Piper Sandler raises to neutral from underweight |
* Texas Roadhouse Inc TXRH.O: Guggenheim raises target price to $185 from $155 |
* Thredup Inc TDUP.O: Telsey Advisory Group cuts target price to $3 from $4 |
* Thredup Inc TDUP.O: Wedbush cuts target price to $3 from $4 |
* Transact Technologies Inc TACT.O: Craig-Hallum cuts target price to $7.5 from $9 |
* Travere Therapeutics Inc TVTX.O: Canaccord Genuity raises target price to $18 from $15 |
* Treehouse Foods Inc THS.N: Stifel cuts target price to $36 from $38 |
* Treehouse Foods Inc THS.N: TD Cowen cuts target price to $37 from $38 |
* Tyson Foods Inc TSN.N: Bernstein raises target price to $72 from $71 |
* Tyson Foods Inc TSN.N: BMO raises target price to $58 from $55 |
* Tyson Foods Inc TSN.N: JP Morgan raises target price to $61 from $59 |
* Tyson Foods Inc TSN.N: Piper Sandler raises target price to $57 from $55 |
* Ul Solutions Inc ULS.N: BofA Global Research initiates coverage with buy rating |
* Ul Solutions Inc ULS.N: BofA Global Research initiates coverage with PT $42 |
* UL Solutions Inc ULS.N: Jefferies initiates coverage with buy rating; price target $42 |
* Ul Solutions Inc ULS.N: Raymond James initiates with outperform rating and $42 PT |
* Ul Solutions Inc ULS.N: Stifel initiates with buy rating and $40 price target |
* Ul Solutions Inc ULS.N: UBS initiates coverage with neutral rating and PT $38 |
* Ulta Beauty Inc ULTA.O: Oppenheimer cuts target price to $475 from $500 |
* Ultra Clean Holdings Inc UCTT.O: Needham raises target price to $56 from $50 |
* Ultra Clean Holdings Inc UCTT.O: TD Cowen raises target price to $55 from $47 |
* Universal Health Services Inc UHS.N: RBC raises target price to $189 from $183 |
* USANA Health Sciences Inc USNA.N: D.A. Davidson cuts target price to $46 from $48 |
* Vale SA VALE.N: UBS raises to buy from neutral; raises target price to $15 from $13 |
* Varonis Systems Inc VRNS.O: RBC raises target price to $58 from $56 |
* Ventas Inc VTR.N: RBC raises target price to $52 from $50 |
* Vertex Pharmaceuticals Inc VRTX.O: Bernstein raises target price to $458 from $450 |
* Vertex Pharmaceuticals Inc VRTX.O: Leerink Partners raises PT to $529 from $511 |
* Vertex Pharmaceuticals Inc VRTX.O: Piper Sandler raises target price to $456 from $450 |
* Vertex Pharmaceuticals Inc VRTX.O: RBC raises target price to $424 from $417 |
* Vimeo Inc VMEO.O: Piper Sandler raises target price to $4.50 from $4 |
* Vistra Corp VST.N: Guggenheim raises target price to $100 from $48 |
* Vistra Corp VST.N: RBC raises target price to $95 from $30 |
* Walmart Inc WMT.N: UBS raises target price to $69 from $63 |
* Welltower Inc WELL.N: RBC raises target price to $101 from $99 |
* Western Midstream Partners LP WES.N: Mizuho raises target price to $39 from $34 |
* Westrock Co WRK.N: Truist Securities raises target price to $51 from $42 |
* Willscot Mobile Mini Holdings Corp WSC.O: D.A. Davidson cuts target price to $54 from $56 |
* Wolfspeed Inc WOLF.N: Deutsche Bank cuts target price to $25 from $30 |
* Zeta Global Holdings Corp ZETA.N: Barclays raises target price to $18 from $15 |
* Zeta Global Holdings Corp ZETA.N: Canaccord Genuity raises PT to $17 from $13 |
* Zeta Global Holdings Corp ZETA.N: Craig-Hallum raises target price to $22 from $15 |
* Zeta Global Holdings Corp ZETA.N: D.A. Davidson raises target price to $19 from $15 |
* Zeta Global Holdings Corp ZETA.N: Needham raises target price to $18 from $13 |
* Zeta Global Holdings Corp ZETA.N: Oppenheimer raises target price to $18 from $14 |
(Compiled by Bengaluru Newsroom)
</body></html>สินทรัพย์ที่เกี่ยวข้อง
ข่าวล่าสุด
ข้อความสงวนสิทธิ์: บริษัทในเครือ XM Group มีการให้บริการดำเนินคำสั่งและการเข้าถึงแพลตฟอร์มซื้อขายออนไลน์ของเรา ซึ่งช่วยให้บุคคลสามารถดู และ/หรือใช้ข้อมูลที่มีอยู่บนหรือผ่านทางเว็บไซต์ ซึ่งไม่ได้มีการเปลี่ยนแปลงหรือขยายความจากสิ่งนี้ อีกทั้งการเข้าถึงดังกล่าวจะอยู่ภายใต้: (i) เงื่อนไขและข้อตกลง; (ii) คำเตือนเกี่ยวกับความเสี่ยง; และ (iii) ข้อความสงวนสิทธิ์ฉบับเต็ม ดังนั้นข้อมูลดังกล่าวจึงเป็นเพียงแค่ข้อมูลทั่วไปเท่านั้น นอกจากนี้โปรดทราบว่าข้อมูลต่างๆ บนแพลตฟอร์มซื้อขายออนไลน์ของเราไม่ได้มีการเชื้อเชิญหรือถือเป็นข้อเสนอให้ทำธุรกรรมใดๆ บนตลาดการเงิน และการซื้อขายบนตลาดการเงินใดๆ มีความเสี่ยงในระดับสูงกับเงินทุนของคุณ
เนื้อหาทั้งหมดที่ถูกเผยแพร่อยู่บนแพลตฟอร์มเทรดออนไลน์ของเรามีวัตถุประสงค์เพื่อให้ข้อมูล/ความรู้เท่านั้นและไม่มี – และไม่ควรถือว่ามี – คำแนะนำด้านการเงิน, ภาษีการลงทุน, หรือการเทรด หรือข้อมูลราคาย้อนหลัง, หรือข้อเสนอ, หรือการเชื้อเชิญให้ทำธุรกรรมใดๆ เกี่ยวกับตราสารทางการเงินหรือโปรโมชั่นทางการเงินสำหรับท่าน
เนื้อหาของบุคคลที่สามใดๆ รวมถึงเนื้อหาที่ถูกจัดเตรียมขึ้นโดย XM เช่น ข้อคิดเห็น, ข่าวสาร, บทวิเคราะห์, ราคา, ข้อมูลอื่นๆ หรือลิงก์ไปยังเว็บไซต์ของบุคคลที่สามที่อยู่ในเว็บไซต์นี้ถูกจัดทำขึ้น “ตามที่เป็น” ซึ่งเป็นการแสดงความคิดเห็นเกี่ยวกับตลาดโดยทั่วไปและไม่ถือเป็นคำแนะนำด้านการลงทุน เนื่องจากเนื้อหาเหล่านี้ถือเป็นบทวิจัยด้านการลงทุน ท่านจะต้องทราบและยอมรับว่า เนื้อหาเหล่านี้ไม่ได้มีวัตถุประสงค์และไม่ได้มีการถูกจัดเตรียมขึ้นตามข้อกำหนดทางด้านกฎหมายที่ถูกออกแบบขึ้นมาเพื่อส่งเสริมการวิจัยด้านการลงทุนที่เป็นอิสระ ดังนั้นเนื้อหาเหล่านี้ถือเป็นการสื่อสารทางการตลาดภายใต้กฎหมายและกฎระเบียบที่เกี่ยวข้อง โปรดอ่านและทำความเข้าใจประกาศเกี่ยวกับบทวิจัยด้านการลงทุนที่ไม่ได้มีความเป็นอิสระและคำเตือนเกี่ยวกับความเสี่ยงซึ่งมีความเกี่ยวข้องกับข้อมูลต่างๆ ดังที่ได้กล่าวไปแล้ว โดยท่านสามารถดูได้ ที่นี่